Ergoteles LLC Ligand Pharmaceuticals Inc Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$65.67 - $77.08 $466,716 - $547,807	-7,107 Reduced 71.96%	2,769 $203,000
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $239,535 - $375,447	3,881 Added 64.74%	9,876 $659,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $59 - $644,822	5,995 New	5,995 $516,000
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $244,978 - $346,483	-2,394 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$113.03 - $155.64 $149,312 - $205,600	-1,321 Reduced 35.56%	2,394 $314,000
Q1 2021 May 12, 2021	BUY	$99.52 - $215.83 $369,716 - $801,808	3,715 New	3,715 $566,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.